We are live on ! Find out more
STIM icon

Neuronetics

66 hedge funds and large institutions have $84.2M invested in Neuronetics in 2024 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

82% more capital invested

Capital invested by funds: $46.2M → $84.2M (+$38M)

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

4.38% more ownership

Funds ownership: 55.05%59.43% (+4.4%)

0% more funds holding

Funds holding: 6666 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

35% less call options, than puts

Call options by funds: $11K | Put options by funds: $17K

Holders
66
Holders Change
Holders Change %
0%
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
11
Increased
21
Reduced
19
Closed
11
Calls
$11K
Puts
$17K
Net Calls
-$6K
Net Calls Change
-$6K
Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Archon Capital Management
Washington
$12.1M
CC
2
Cannell Capital
Wyoming
$11.7M -$1.08M -306,012 -11%
DSCM
3
Divisadero Street Capital Management
Florida
$7.33M +$5.41M +1,539,447 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$6.19M -$187K -53,229 -4%
SAM
5
Silvercrest Asset Management
New York
$5.61M +$182K +51,881 +5%
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
$5.57M -$872K -248,217 -18%
KLC
7
Kent Lake Capital
Nevada
$4.86M -$333K -94,890 -9%
First Eagle Investment Management
8
First Eagle Investment Management
New York
$3.71M +$10.5K +3,000 +0.4%
MAG
9
Millrace Asset Group
Pennsylvania
$3.6M +$110K +31,435 +4%
FWC
10
First Washington Corp
Washington
$3.21M +$718K +204,402 +43%
GIPM
11
G2 Investment Partners Management
New York
$3.13M +$2.05M +583,937 +797%
BlackRock
12
BlackRock
New York
$1.81M +$1.46K +415 +0.1%
DCM
13
DAFNA Capital Management
California
$1.49M
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.36M +$73.9K +21,040 +8%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$1.26M -$120K -34,172 -11%
Marshall Wace
16
Marshall Wace
United Kingdom
$1.04M +$261K +74,311 +52%
BFM
17
Boothbay Fund Management
New York
$771K +$505K +143,689 +782%
HighTower Advisors
18
HighTower Advisors
Illinois
$753K -$87.9K -25,000 -14%
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$700K +$114K +32,353 +28%
Renaissance Technologies
20
Renaissance Technologies
New York
$683K -$89.6K -25,500 -15%
State Street
21
State Street
Massachusetts
$486K
Citadel Advisors
22
Citadel Advisors
Florida
$435K +$33.2K +9,458 +12%
TSW
23
Thompson Siegel & Walmsley
Virginia
$422K -$349K -99,211 -53%
Assenagon Asset Management
24
Assenagon Asset Management
Luxembourg
$396K -$10.1K -2,866 -3%
BCM
25
Bridgeway Capital Management
Texas
$395K +$70.3K +20,000 +32%

STIM Hedge Fund Activity: Q1 2024 in Review

66 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Neuronetics (STIM) for Q1 2024, worth a combined $84.2M — up 82% from $46.2M a quarter earlier.

Fund positioning in STIM was balanced in Q1 2024: 11 funds opened new positions, 11 closed out, 21 added to existing stakes and 19 trimmed.

The largest buyer was Divisadero Street Capital Management, opening a new position worth an estimated $5.41M. The largest seller was Cannell Capital, cutting an estimated $1.08M.

  • 66 institutional investors held Neuronetics (STIM) as of Q1 2024, unchanged from Q4 2023.
  • Funds reported $84.2M of Neuronetics stock for Q1 2024, up 82% quarter-over-quarter.
  • 11 funds opened new Neuronetics positions in Q1 2024 and 11 closed out, a net change of 0 holders.
  • The largest Neuronetics buyer in Q1 2024 was Divisadero Street Capital Management, an estimated $5.41M added.
  • The largest Neuronetics seller in Q1 2024 was Cannell Capital, an estimated $1.08M sold.

Based on aggregated 13F filings for Q1 2024.